• About us

    About us

    Futura Medical is the developer of innovative sexual health products, including lead product Eroxon®. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products. 

    Explore this section
    • Who we are
    • Our business model
    • Our strategy
    • Board of directors
  • Eroxon®

    Eroxon®

    Our lead product is Eroxon®a clinically proven breakthrough treatment for erectile dysfunction

    • What is Eroxon®
    • Eroxon® at a glance
    • Clinical data
    • Marketplace
    • Commercial partners
    • Commercialisation
    • Products FAQs

      Products FAQs

      • Eroxon® FAQs
  • Investor centre

    Investor centre

    Futura has a proven track record in delivery and completion of Research & Development projects up to value inflection points at which they are suitable for commercialisation partners.

    WEBCASTS

    Explore this section
    • Share price chart
    • Corporate documentation
    • Videos and webcasts

      Videos and webcasts

      • Videos
      • Webcasts
    • RNS
    • Alert service
    • Shareholder centre

      Shareholder centre

      • Investor contacts and advisors
      • Shareholder information
      • Financial calendar
      • Investor FAQs
      • Analyst Research
    • Corporate Governance
    • AIM rule 26
  • Media

    Media

    This section contains the latest RNS, news and videos.

    Explore this section
    • News
    • Event calendar
    • RNS
    • Videos
    • Alert service
  • Contact us
  • About us
    • Who we are
    • Our business model
    • Our strategy
    • Board of directors
  • Eroxon®
    • What is Eroxon®
    • Eroxon® at a glance
    • Clinical data
    • Marketplace
    • Commercial partners
    • Commercialisation
    • Products FAQs
      • Eroxon® FAQs
        • What if Eroxon® is used in combination with PDE5is? Will post-approval studies be necessary?
  • Investor centre
    • Share price chart
    • Corporate documentation
    • Videos and webcasts
      • Videos
        • Futura Medical announces enhanced Eroxon Gel for ED and female sexual dysfunction product
      • Webcasts
    • RNS
    • Alert service
    • Shareholder centre
      • Investor contacts and advisors
      • Shareholder information
      • Financial calendar
        • Notice of results for the six months ended 30 June 2024
      • Investor FAQs
      • Analyst Research
    • Corporate Governance
    • AIM rule 26
  • Media
    • News
    • Event calendar
    • RNS
    • Videos
    • Alert service
  • Contact us
    Sitemap

    Sitemap

    • Home
    • Site essentials

    • Sitemap

    • About us
      • Who we are
      • Our business model
      • Our strategy
      • Board of directors

    • Eroxon®

      • What is Eroxon®
      • Eroxon® at a glance
      • Clinical data
      • Marketplace
      • Commercial partners
      • Commercialisation
      • Products FAQs
        • Eroxon® FAQs
    • Investor centre
      • Share price chart
      • Corporate documentation
      • Videos and webcasts
        • Videos
        • Webcasts
      • RNS
      • Alert service
      • Shareholder centre
        • Investor contacts and advisors
        • Shareholder information
        • Financial calendar
        • Investor FAQs
        • Analyst Research
      • Corporate Governance
      • AIM rule 26
    • Media
      • News
      • Event calendar
      • RNS
      • Videos
      • Alert service
    • Contact us
    • Site Essentials
      • Accessibility
      • Terms of use
      • Privacy & cookies policies

    ©2024 Futura Medical

    • Sitemap
    • Contact us
    • Accessibility
    • Terms of use
    • Privacy & cookies policies

    ©2024 Futura Medical

    Designed and developed by
    jonesandpalmer.co.uk